: The AMEDEO Literature Guide

Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Multiple Sclerosis

Free Subscription

Articles published in Mult Scler
Retrieve available abstracts of 447 articles:
HTML format
Text format

Single Articles

March 2010

MASTORODEMOS V , Nikolakaki H, Tzagournissakis M, Kotzamani D, et al
Benign multiple sclerosis in Crete*
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

TALLANTYRE EC , Bo L, Al-Rawashdeh O, Owens T, et al
Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BENTZEN J , Flachs EM, Stenager E, Bronnum-Hansen H, et al
Prevalence of multiple sclerosis in Denmark 1950-2005.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GORGORAPTIS N , Wheeler-Kingshott CA, Jenkins TM, Altmann DR, et al
Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LARON M , Cheng H, Zhang B, Schiffman JS, et al
Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GIJBELS D , Alders G, Van Hoof E, Charlier C, et al
Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GONSETTE RE , Sindic C, D'hooghe MB, De Deyn PP, et al
Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon {beta} in relapsing-remitting Multiple Sclerosis (ASIIMS) trial.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

DE STEFANO N , Curtin F, Stubinski B, Blevins G, et al
Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

HAWKES CH , Giovannoni G
The McDonald Criteria for Multiple Sclerosis: time for clarification.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

DIAZ-SANCHEZ M , Gomez-Moreno SM, Morales-Otal MA, Ramos-Gonzalez A, et al
Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

STANKOVIC A , Dincic E, Ristic S, Lovrecic L, et al
Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

POMEROY I , Jordan E, Frank J, Matthews P, et al
Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LAZZARINO G , Amorini A, Eikelenboom M, Killestein J, et al
Cerebrospinal fluid ATP metabolites in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

DELOIRE M , Ruet A, Hamel D, Bonnet M, et al
Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KOUNTOURAS J , Gavalas E, Deretzi G, Boziki M, et al
Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica.
Mult Scler. 2010;16:376-7.
PubMed Text format Related articles

BERETICH BD , Beretich TM
Authors' reply to 'Latitude and multiple sclerosis prevalence: vitamin D reduces risk of Epstein--Barr virus infection'.
Mult Scler. 2010;16:374-5.
PubMed Text format Related articles

POORJAVAD M , Derakhshandeh F, Etemadifar M, Soleymani B, et al
Oropharyngeal dysphagia in multiple sclerosis.
Mult Scler. 2010;16:362-5.
PubMed Text format Related articles Abstract available

COMABELLA M , Montalban X, Horga A, Messmer B, et al
Antiviral immune response in patients with multiple sclerosis and healthy siblings.
Mult Scler. 2010;16:355-8.
PubMed Text format Related articles Abstract available

KHALEELI Z , Ciccarelli O, Mizskiel K, Altmann D, et al
Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
Mult Scler. 2010;16:317-24.
PubMed Text format Related articles Abstract available

BLECHARZ KG , Haghikia A, Stasiolek M, Kruse N, et al
Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.
Mult Scler. 2010;16:293-302.
PubMed Text format Related articles Abstract available

February 2010

VASCONCELOS CC , Thuler LC, Dos Santos GA, Alvarenga MP, et al
Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

ZHAO Y , Petkau A, Traboulsee A, Riddehough A, et al
Does MRI lesion activity regress in secondary progressive multiple sclerosis?
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BERMEL R , Weinstock-Guttman B, Bourdette D, Foulds P, et al
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

FINK F , Eling P, Rischkau E, Beyer N, et al
The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KIRA JI , Minohara M, Li W, Matsushita T, et al
Authors' reply to Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica.
Mult Scler. 2010.
PubMed Text format Related articles

LANZILLO R , Orefice G, Quarantelli M, Rinaldi C, et al
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

QIU W , Bundell C, Wu JS, Castley A, et al
Low level of systemic autoimmunity in Western Australian multiple sclerosis patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PROSPERINI L , Leonardi L, De Carli P, Mannocchi ML, et al
Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

INGRAM G , Colley E, Ben-Shlomo Y, Cossburn M, et al
Validity of patient-derived disability and clinical data in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

YADAV V , Marracci GH, Munar MY, Cherala G, et al
Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

OZTURK A , Smith S, Gordon-Lipkin E, Harrison D, et al
MRI of the corpus callosum in multiple sclerosis: association with disability.
Mult Scler. 2010;16:166-77.
PubMed Text format Related articles Abstract available

January 2010

FORD C , Goodman AD, Johnson K, Kachuck N, et al
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis : results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SWANTON J , Fernando K, Dalton C, Miszkiel K, et al
Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SINCLAIR V , Shepard G
Symptomatic, steroid-induced, multifocal diaphyseal osteonecrosis in a patient with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PAPADOPOULOS K , Tozer DJ, Fisniku L, Altmann DR, et al
T1-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

WINSEN LM , Polman CH, Dijkstra CD, Tilders FJ, et al
Suppressive effect of glucocorticoids on TNF-{alpha} production is associated with their clinical effect in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

VOGT MH , Ten Kate J, Drent RJ, Polman CH, et al
Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MESAROS S , Rocca M, Sormani M, Valsasina P, et al
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SOMER E , Golan D, Dishon S, Cuzin-Disegni L, et al
Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapse.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MAGHZI A , Ghazavi H, Ahsan M, Etemadifar M, et al
Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

FREEDMAN MS , Bar-Or A, Atkins HL, Karussis D, et al
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

WINSEN LM , Kragt JJ, Hoogervorst EL, Polman CH, et al
Outcome measurement in multiple sclerosis: detection of clinically relevant improvement.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SALZER J , Svenningsson A, Sundstrom P
Neurofilament light as a prognostic marker in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

REUB R , Schreiber V, Klein A, Infante-Duarte C, et al
No significant effect of orally administered chemokine receptor 1 antagonist on intercellular adhesion molecule-3 expression in relapsing-remitting multiple sclerosis patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

RAMAGOPALAN SV , Sadovnick AD, Ebers GC, Giovannoni G, et al
Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
Mult Scler. 2010;16:127-8.
PubMed Text format Related articles

PELAYO R , Montalban X, Minoves T, Moncho D, et al
Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?
Mult Scler. 2010;16:55-61.
PubMed Text format Related articles Abstract available

GOTTESMAN MH , Friedman-Urevich S, Boylan E, Cheng D, et al
Neutralizing antibodies to 500 microg interferon beta-1b: 28-month results of the IDEAS extension trial.
Mult Scler. 2010;16:78-80.
PubMed Text format Related articles Abstract available

ADONI T , Lino AM, da Gama PD, Apostolos-Pereira SL, et al
Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics.
Mult Scler. 2010;16:81-6.
PubMed Text format Related articles Abstract available

December 2009

MEHTA LR , McDermott MP, Goodman AD, Schwid SR, et al
A randomized trial of memantine as treatment for spasticity in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ISOBE N , Matsushita T, Yamasaki R, Ramagopalan S, et al
Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

DRAKE A , Weinstock-Guttman B, Morrow S, Hojnacki D, et al
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CALAIS G , Forzy G, Crinquette C, Mackowiak A, et al
Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

GRANT WB
Latitude and multiple sclerosis prevalence: vitamin D reduces risk of Epstein-Barr virus infection.
Mult Scler. 2009.
PubMed Text format Related articles

COMI G , O'Connor P, Montalban X, Antel J, et al
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

PRINSTER A , Quarantelli M, Lanzillo R, Orefice G, et al
A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MENDOZZI L , Tronci F, Garegnani M, Pugnetti L, et al
Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HOHLFELD R
'Gimme five': future challenges in multiple sclerosis. ECTRIMS Lecture 2009.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

SIMON KC , Munger KL, Yang X, Ascherio A, et al
Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MELLERGARD J , Edstrom M, Vrethem M, Ernerudh J, et al
Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

PFLEGER CC , Flachs EM, Koch-Henriksen N
Social consequences of multiple sclerosis (1): early pension and temporary unemployment--a historical prospective cohort study.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

SPANO B , Cercignani M, Basile B, Romano S, et al
Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CHIARINI M , Sottini A, Ghidini C, Zanotti C, et al
Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

JENSEN MA , Yanowitch RN, Reder AT, White DM, et al
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon B-1b.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

RAMIL E , Sanchez AJ, Gonzalez-Perez P, Rodriguez-Antiguedad A, et al
The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

FEINSTEIN A , O'Connor P, Akbar N, Moradzadeh L, et al
Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

WU JS , Qiu W, Castley A, James I, et al
Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

LONERGAN R , Kinsella K, Duggan M, Jordan S, et al
Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ZELLINI F , Niepel G, Tench CR, Constantinescu CS, et al
Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

PATTI F , Amato MP, Bastianello S, Caniatti L, et al
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BRUM DG , Barreira AA, Santos AC, Kaimen-Maciel DR, et al
HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

REIBER H , Teut M, Pohl D, Rostasy KM, et al
Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerabrospinal fluid.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MONTALBAN X , Sastre-Garriga J, Filippi M, Khaleeli Z, et al
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

URBANEK C , Weinges-Evers N, Bellmann-Strobl J, Bock M, et al
Attention Network Test reveals alerting network dysfunction in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

LARON M , Cheng H, Zhang B, Schiffman JS, et al
Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

PENNER IK , Raselli C, Stocklin M, Opwis K, et al
The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ZIPOLI V , Goretti B, Hakiki B, Siracusa G, et al
Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BRUCE J , Hancock LM, Lynch SG
Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

GIORDANO A , Messmer Uccelli M, Pucci E, Martinelli V, et al
The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

IDRIS MN , Sokrab TE, Ibrahim EA, Ali HE, et al
Multiple sclerosis in Sudan: a prospective study of clinical presentation and outcome.
Mult Scler. 2009;15:1537-8.
PubMed Text format Related articles

BERGAMASCHI R , Montomoli C
Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence?
Mult Scler. 2009;15:1532-3.
PubMed Text format Related articles Abstract available

November 2009

LI W , Minohara M, Piao H, Matsushita T, et al
Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

WU XM , Wang C, Zhang KN, Lin AY, et al
Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HONARMAND K , Feinstein A
Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

PORTACCIO E , Goretti B, Zipoli V, Nacmias B, et al
APOE-{varepsilon}4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MACALLISTER WS , Christodoulou C, Troxell R, Milazzo M, et al
Fatigue and Quality of Life in Pediatric Multiple Sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CECCARELLI A , Rocca MA, Neema M, Martinelli V, et al
Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

DAHL OP , Stordal E, Lydersen S, Midgard R, et al
Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

WILKINS A , Ingram G, Brown A, Jardine P, et al
Very long chain fatty acid levels in patients diagnosed with multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

NAKAMURA M , Houzen H, Niino M, Tanaka K, et al
Relationship between Barkhof criteria and the clinical features of multiple sclerosis in northern Japan.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HOTERMANS C , Belachew S, Moonen G, Delwaide J, et al
Severe liver dysfunction in a patient with multiple sclerosis: the guilty party is not always the disease-modifying therapy.
Mult Scler. 2009;15:1378-9.
PubMed Text format Related articles

SOE SH , Kopsky DJ, Jongen PJ, de Vet HC, et al
Multiple sclerosis patients with bladder dysfunction have decreased symptoms after electro-acupuncture.
Mult Scler. 2009;15:1376-7.
PubMed Text format Related articles

BENESOVA Y
Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
Mult Scler. 2009;15:1374-5.
PubMed Text format Related articles

VEUGELERS PJ , Fisk JD, Brown MG, Stadnyk K, et al
Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation.
Mult Scler. 2009;15:1286-94.
PubMed Text format Related articles Abstract available

JUNG K
Consideration of preanalytical impact of blood sampling on measurement of matrix metalloproteinases and their inhibitors as precondition to evaluate their relationship to clinical data.
Mult Scler. 2009;15:1372-3.
PubMed Text format Related articles

CUTTER G
Evidence of treatment benefit: is seeing believing or obfuscation by statistics?
Mult Scler. 2009;15:1251-2.
PubMed Text format Related articles

October 2009

WAYNE MOORE GR , Vitali AM, Leung E, Laule C, et al
Thalamic stimulation in multiple sclerosis: evidence for a 'demyelinative thalamotomy'?
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HUGHES CM , Smyth S, Lowe-Strong AS
Reflexology for the treatment of pain in people with multiple sclerosis: a double-blind randomised sham-controlled clinical trial.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

YAMOUT B , Usta J, Itani S, Yaghi S, et al
Celiac disease, Behcet, and idiopathic thrombocytopenic purpura in siblings of a patient with multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

PASCUAL AM , Tellez N, Bosca I, Mallada J, et al
Revision of the risk of secondary leukemia after mitoxantrone in multiple sclerosis populations is required.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

RINALDI F , Perini P, Calabrese M, Rinaldi L, et al
Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CORDELLA R , Franzini A, La Mantia L, Marras C, et al
Hypothalamic stimulation for trigeminal neuralgia in multiple sclerosis patients: efficacy on the paroxysmal ophthalmic pain.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

SMESTAD C , Sandvik L, Celius EG
Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HOLMOY T , Moen SM, Gundersen TA, Holick MF, et al
25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

FREEDMAN MS
"Time is brain" also in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles

BOSTROM I , Callander M, Kurtzke JF, Landtblom AM, et al
High prevalence of multiple sclerosis in the Swedish county of Varmland.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

FESTA ED , Hankiewicz K, Kim S, Skurnick J, et al
Serum levels of CXCL13 are elevated in active multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

RIVERA-NAVARRO J , Benito-Leon J, Oreja-Guevara C, Pardo J, et al
Burden and health-related quality of life of Spanish caregivers of persons with multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CASETTA I , Riise T, Nortvedt MW, Economou NT, et al
Gender differences in health-related quality of life in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

DE ABREU DA , Babron MC, Rebeix C, Fontenille J, et al
Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis.
Mult Scler. 2009;15:1146-52.
PubMed Text format Related articles Abstract available

GARCEA O , Villa A, Caceres F, Adoni T, et al
Early treatment of multiple sclerosis: a Latin American experts meeting.
Mult Scler. 2009;15 Suppl 3:S1-S12.
PubMed Text format Related articles Abstract available

September 2009

NEUTEBOOM RF , Verbraak E, Voerman JS, van Meurs M, et al
First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MONTALBAN X , Sastre-Garriga J, Tintore M, Brieva L, et al
A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BIELEKOVA B , Richert N, Howard T, Packer AN, et al
Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood-brain barrier disruption in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

METZ LM , Li D, Traboulsee A, Myles ML, et al
Glatiramer Acetate in Combination with Minocycline in Patients with Relapsing-Remitting Multiple Sclerosis: Results of a Canadian, Multicenter, Double-Blind, Placebo-Controlled Trial.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

GOODIN DS , Bates D
Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

WESSON JM , Cooper JA, Jehle LS, Lockhart SN, et al
The functional index for living with multiple sclerosis: development and validation of a new quality of life questionnaire.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ETEMADIFAR M , Fatehi F, Sahraian M, Borhanihaghighi A, et al
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.
Mult Scler. 2009;15:1126-30.
PubMed Text format Related articles Abstract available

WEBER-SCHOENDORFER C , Schaefer C
Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.
Mult Scler. 2009;15:1037-42.
PubMed Text format Related articles Abstract available

PODBIELSKA M , Hogan E
Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?
Mult Scler. 2009;15:1011-29.
PubMed Text format Related articles Abstract available

Abstracts of the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. September 9-12, 2009. Dusseldorf, Germany.
Mult Scler. 2009;15 Suppl 2:S5-277.
PubMed Text format Related articles

Abstract of Multiple Sclerosis 2009.
Mult Scler. 2009;15.
PubMed Text format Related articles

August 2009

HAMILTON F , Rochester L, Paul L, Rafferty D, et al
Walking and talking: an investigation of cognitive-motor dual tasking in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

TIEMANN L , Penner I, Haupts M, Schlegel U, et al
Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MORROW S , Weinstock-Guttman B, Munschauer F, Hojnacki D, et al
Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
Mult Scler. 2009;15:998-1005.
PubMed Text format Related articles Abstract available

RUDICK R , Polman C, Cohen J, Walton M, et al
Assessing disability progression with the Multiple Sclerosis Functional Composite.
Mult Scler. 2009;15:984-997.
PubMed Text format Related articles Abstract available

BAR-OR A , Oger J, Gibbs E, Niino M, et al
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?
Mult Scler. 2009;15:959-64.
PubMed Text format Related articles Abstract available

CALABRESE M , Gallo P
Magnetic resonance evidence of cortical onset of multiple sclerosis.
Mult Scler. 2009;15:933-41.
PubMed Text format Related articles Abstract available

SIVA A , Saip S, Altintas A, Jacob A, et al
Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
Mult Scler. 2009;15:918-27.
PubMed Text format Related articles Abstract available

NEUTEBOOM R , Verbraak E, Voerman J, van Meurs M, et al
Serum leptin levels during pregnancy in multiple sclerosis.
Mult Scler. 2009;15:907-12.
PubMed Text format Related articles Abstract available

PEDOTTI R , Farinotti M, Falcone C, Borgonovo L, et al
Allergy and multiple sclerosis: a population-based case-control study.
Mult Scler. 2009;15:899-906.
PubMed Text format Related articles Abstract available

BERETICH B , Beretich T
Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.
Mult Scler. 2009;15:891-8.
PubMed Text format Related articles Abstract available

EBERS G
Editorial regarding "Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis," by Beretich and Beretich.
Mult Scler. 2009;15:889-90.
PubMed Text format Related articles

PELLKOFER HL , Suessmair C, Schulze A, Hohlfeld R, et al
Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab.
Mult Scler. 2009;15:1006-8.
PubMed Text format Related articles Abstract available

CENIT MD , Blanco-Kelly F, de las Heras V, Bartolome M, et al
Glypican 5 is an interferon-beta response gene: a replication study.
Mult Scler. 2009;15:913-7.
PubMed Text format Related articles Abstract available

MILLONIG A , Rudzki D, Holzl M, Ehling R, et al
High-dose intravenous interferon beta in patients with neutralizing antibodies (HINABS): a pilot study.
Mult Scler. 2009;15:977-83.
PubMed Text format Related articles Abstract available

July 2009

CHANSON J , Kremer S, Blanc F, Marescaux C, et al
Foreign accent syndrome as a first sign of multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

COCCO E , Sardu C, Murru R, Frau J, et al
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HEESEN C , Schaffler N, Kasper J, Muhlhauser I, et al
Suspected multiple sclerosis - what to do? Evaluation of a patient information leaflet.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

RADZISZEWSKI P , Crayton R, Zaborski J, Czlonkowska A, et al
Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity.
Mult Scler. 2009;15:860-8.
PubMed Text format Related articles Abstract available

VALENTINO P , Cerasa A, Chiriaco C, Nistico R, et al
Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
Mult Scler. 2009;15:854-9.
PubMed Text format Related articles Abstract available

PATTI F , Amato M, Trojano M, Bastianello S, et al
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Mult Scler. 2009;15:779-788.
PubMed Text format Related articles Abstract available

BENEDICT R
Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis.
Mult Scler. 2009;15:777-8.
PubMed Text format Related articles

GLAD S , Nyland H, Aarseth J, Riise T, et al
Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BONZANO L , Roccatagliata L, Mancardi G, Sormani M, et al
Gadolinium-enhancing or active T2 magnetic resonance imaging lesions in multiple sclerosis clinical trials?
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CHONG HT , Kira J, Tsai CP, Ong B, et al
Proposed modifications to the McDonald criteria for use in Asia.
Mult Scler. 2009;15:887-8.
PubMed Text format Related articles

RIO J , Castillo J, Rovira A, Tintore M, et al
Measures in the first year of therapy predict the response to interferon beta in MS.
Mult Scler. 2009;15:848-53.
PubMed Text format Related articles Abstract available

CABRERA-GOMEZ JA , Bonnan M, Gonzalez-Quevedo A, Saiz-Hinarejos A, et al
Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies.
Mult Scler. 2009;15:828-33.
PubMed Text format Related articles Abstract available

YEH EA , Weinstock-Guttman B, Lincoff N, Reynolds J, et al
Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset.
Mult Scler. 2009;15:802-10.
PubMed Text format Related articles Abstract available

June 2009

KHALIL M , Enzinger C, Langkammer C, Tscherner M, et al
Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

DOWARD L , McKenna S, Meads D, Twiss J, et al
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

UKKONEN M , Vahvelainen T, Hamalainen P, Dastidar P, et al
Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CREANGE A , Debouverie M, Jaillon-Riviere V, Taithe F, et al
Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

STROBER L , Englert J, Munschauer F, Weinstock-Guttman B, et al
Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

KLISTORNER A , Arvind H, Nguyen T, Garrick R, et al
Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

SILVA A , Bettencourt A, Pereira C, Santos E, et al
Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
Mult Scler. 2009;15:771-4.
PubMed Text format Related articles Abstract available

STELMASIAK Z , Solski J, Nowicki J, Jakubowska B, et al
Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, crossover study.
Mult Scler. 2009;15:767-70.
PubMed Text format Related articles Abstract available

GANESVARAN G , Greer J, Pender M
Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis.
Mult Scler. 2009;15:763-6.
PubMed Text format Related articles Abstract available

CECCARELLI A , Filippi M, Neema M, Arora A, et al
T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis.
Mult Scler. 2009;15:678-86.
PubMed Text format Related articles Abstract available

KERN S , Schrempf W, Schneider H, Schultheiss T, et al
Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.
Mult Scler. 2009;15:752-758.
PubMed Text format Related articles Abstract available

O'CONNOR P , Kinkel RP, Kremenchutzky M
Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria.
Mult Scler. 2009;15:728-34.
PubMed Text format Related articles Abstract available

HOLST B , Siemonsen S, Finsterbusch J, Bester M, et al
T2' imaging indicates decreased tissue metabolism in frontal white matter of MS patients.
Mult Scler. 2009;15:701-7.
PubMed Text format Related articles Abstract available

HAWKES CH , Macgregor AJ
Twin studies and the heritability of MS: a conclusion.
Mult Scler. 2009;15:661-7.
PubMed Text format Related articles Abstract available

NAKAMURA M , Misu T, Fujihara K, Miyazawa I, et al
Occurrence of acute large and edematous callosal lesions in neuromyelitis optica.
Mult Scler. 2009;15:695-700.
PubMed Text format Related articles Abstract available

ROOSENDAAL SD , Moraal B, Pouwels PJ, Vrenken H, et al
Accumulation of cortical lesions in MS: relation with cognitive impairment.
Mult Scler. 2009;15:708-14.
PubMed Text format Related articles Abstract available

May 2009

LEDINEK A , Jazbec S, Drinovec I, Rot U, et al
Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MATSUSHITA T , Isobe N, Matsuoka T, Shi N, et al
Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BENEDETTI B , Rovaris M, Rocca M, Caputo D, et al
In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ANDERSON V , Fisniku L, Altmann D, Thompson A, et al
MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

AL-IZKI S , Pryce G, Giovannoni G, Baker D, et al
Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CARROLL W
Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

KHAN F , Turner-Stokes L, Stevermuer T, Simmonds F, et al
Multiple sclerosis rehabilitation outcomes: analysis of a national casemix data set from Australia.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ANDREASEN A , Jakobsen J, Petersen T, Andersen H, et al
Fatigued patients with multiple sclerosis have impaired central muscle activation.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HAVRDOVA E , Zivadinov R, Krasensky J, Dwyer M, et al
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CHENG Q , Cheng XJ, Jiang GX
Multiple sclerosis in China--history and future.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HON G , Hassan M, van Rensburg S, Abel S, et al
Erythrocyte membrane fatty acids in patients with multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

FISNIKU L , Altmann D, Cercignani M, Tozer D, et al
Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

FURBY J , Hayton T, Altmann D, Brenner R, et al
Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MARRIE R , Horwitz R, Cutter G, Tyry T, et al
Measuring up rates for adverse health behaviors in multiple sclerosis: the need for action.
Mult Scler. 2009;15:648.
PubMed Text format Related articles

LIANG J , Zhang H, Hua B, Wang H, et al
Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis.
Mult Scler. 2009;15:644-6.
PubMed Text format Related articles Abstract available

GARDENER H , Munger K, Chitnis T, Spiegelman D, et al
The relationship between handedness and risk of multiple sclerosis.
Mult Scler. 2009;15:587-92.
PubMed Text format Related articles Abstract available

MEHTA L , Schwid S, Arnold D, Cutter G, et al
Proof of concept studies for tissue-protective agents in multiple sclerosis.
Mult Scler. 2009;15:542-546.
PubMed Text format Related articles Abstract available

SATOH J , Tabunoki H, Yamamura T
Molecular network of the comprehensive multiple sclerosis brain-lesion proteome.
Mult Scler. 2009;15:531-41.
PubMed Text format Related articles Abstract available

HAN M , Steinman L
Systems biology for identification of molecular networks in multiple sclerosis.
Mult Scler. 2009;15:529-30.
PubMed Text format Related articles

BROWN TR
Measuring up rates for adverse health behaviors in MS.
Mult Scler. 2009;15:647.
PubMed Text format Related articles

MINNEBOO A , Uitdehaag BM, Jongen P, Vrenken H, et al
Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
Mult Scler. 2009;15:632-7.
PubMed Text format Related articles Abstract available

BICHUETTI DB , Oliveira EM, Souza NA, Rivero RL, et al
Neuromyelitis optica in Brazil: a study on clinical and prognostic factors.
Mult Scler. 2009;15:613-9.
PubMed Text format Related articles Abstract available

ZEPHIR H , Fajardy I, Outteryck O, Blanc F, et al
Is neuromyelitis optica associated with human leukocyte antigen?
Mult Scler. 2009;15:571-9.
PubMed Text format Related articles Abstract available

April 2009

DICKINSON J , Perera D, van der Mei A, Ponsonby AL, et al
Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BOSMA L , Kragt J, Brieva L, Khaleeli Z, et al
The search for responsive clinical endpoints in primary progressive multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

KOBELT G , Texier-Richard B, Lindgren P
The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HIREMATH G , Cettomai D, Baynes M, Ratchford J, et al
Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BERNAL F , Elias B, Hartung H, Kieseier B, et al
Regulation of matrix metalloproteinases and their inhibitors by interferon-{beta}: a longitudinal study in multiple sclerosis patients.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

HAARTSEN J , Marriott M, Butzkueven H
Re: Early relapses after the first dose of natalizumab in active multiple sclerosis.
Mult Scler. 2009;15:520.
PubMed Text format Related articles

RITHIDECH K , Honikel L, Milazzo M, Madigan D, et al
Protein expression profiles in pediatric multiple sclerosis: potential biomarkers.
Mult Scler. 2009;15:455-64.
PubMed Text format Related articles Abstract available

FREEDMAN M , Laks J, Dotan N, Altstock R, et al
Anti-{alpha}-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event.
Mult Scler. 2009;15:422-30.
PubMed Text format Related articles Abstract available

ASANO M , Dawes Dj, Arafah A, Moriello C, et al
What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials?
Mult Scler. 2009;15:412-21.
PubMed Text format Related articles Abstract available

TINTORE M , Sastre-Garriga J
Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes.
Mult Scler. 2009;15:407-8.
PubMed Text format Related articles

MEHTA L , Rose J
Recurrent granuloma annulare during treatment with daclizumab.
Mult Scler. 2009;15:527-8.
PubMed Text format Related articles

KILLESTEIN J , Jasperse B, Liedorp M, Seewann A, et al
Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodies.
Mult Scler. 2009;15:525-6.
PubMed Text format Related articles

FLOHIL M , Verheul G, Schuuring J
Is it a relapse?
Mult Scler. 2009;15:523-4.
PubMed Text format Related articles

BONNAN M , Valentino R, Olindo S, Mehdaoui H, et al
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder.
Mult Scler. 2009;15:487-92.
PubMed Text format Related articles Abstract available

MAYO N , Asano M
Not another meta-analysis!
Mult Scler. 2009;15:409-11.
PubMed Text format Related articles

ELLIS R , Boggild M
Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
Mult Scler. 2009;15:505-8.
PubMed Text format Related articles Abstract available

KNEIDER M , Bergstrom T, Gustafsson C, Nenonen N, et al
Sequence analysis of human rhinovirus aspirated from the nasopharynx of patients with relapsing-remitting MS.
Mult Scler. 2009;15:437-42.
PubMed Text format Related articles Abstract available

SALTER AR , Conger A, Frohman TC, Zivadinov R, et al
Retinal architecture predicts pupillary reflex metrics in MS.
Mult Scler. 2009;15:479-86.
PubMed Text format Related articles Abstract available

HASHIMOTO S , Ball Nj, Tremlett H
Progressive lipoatrophy after cessation of glatiramer acetate injections: a case report.
Mult Scler. 2009;15:521-2.
PubMed Text format Related articles

March 2009

PORTACCIO E , Goretti B, Lori S, Zipoli V, et al
The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CHEN Y , Lin H, Lin H
Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

FAINARDI E , Castellazzi M, Tamborino C, Trentini A, et al
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

WHITE A , Lee J, Light A, Light K, et al
Brain activation in multiple sclerosis: a BOLD fMRI study of the effects of fatiguing hand exercise.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

CHITNIS T , Glanz B, Jaffin S, Healy B, et al
Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

KOCH-HENRIKSEN N , Sorensen P, Bendtzen K, Flachs E, et al
The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

LODE K , Bru E, Klevan G, Myhr K, et al
Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

FERNANDEZ LIGUORI N , Klajn D, Acion L, Caceres F, et al
Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ZEPHIR H , Lefranc D, Dubucquoi S, de Seze J, et al
Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BARRETT C , Mann G, Taylor P, Strike P, et al
A randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ARRONDO G , Alegre M, Sepulcre J, Iriarte J, et al
Abnormalities in brain synchronization are correlated with cognitive impairment in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

STICH O , Janowitz D, Rauer S
Spontaneous intracerebral hemorrhage in a patient with multiple sclerosis and tumefactive demyelinating lesion.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

PORTACCIO E , Zipoli V, Goretti B, De Stefano N, et al
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
Mult Scler. 2009;15:403.
PubMed Text format Related articles

JULIAN L , Vella L, Frankel D, Minden S, et al
ApoE alleles, depression and positive affect in multiple sclerosis.
Mult Scler. 2009;15:311-315.
PubMed Text format Related articles Abstract available

GRAY O , Abdeen H, McDonnell G, Patterson C, et al
An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.
Mult Scler. 2009;15:299-303.
PubMed Text format Related articles Abstract available

FAZEKAS F , Thompson A
New MRI techniques and "aggressive" multiple sclerosis.
Mult Scler. 2009;15:283-4.
PubMed Text format Related articles

PICHIECCHIO A , Tavazzi E, Maccabelli G, Precupanu CM, et al
What insights have new imaging techniques given into aggressive forms of MS--different forms of MS or different from MS?
Mult Scler. 2009;15:285-93.
PubMed Text format Related articles Abstract available

ANTULOV R , Weinstock-Guttman B, Cox JL, Hussein S, et al
Gender-related differences in MS: a study of conventional and nonconventional MRI measures.
Mult Scler. 2009;15:345-54.
PubMed Text format Related articles Abstract available

DOI H , Matsushita T, Isobe N, Matsuoka T, et al
Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody.
Mult Scler. 2009;15:304-10.
PubMed Text format Related articles Abstract available

February 2009

SARESELLA M , Rolland A, Marventano I, Cavarretta R, et al
Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

PATRICK E , Christodoulou C, Krupp L
Longitudinal correlates of fatigue in multiple sclerosis.
Mult Scler. 2009;15:258-261.
PubMed Text format Related articles Abstract available

DEBOUVERIE M , Laforest L, Van Ganse E, Guillemin F, et al
Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.
Mult Scler. 2009;15:251-257.
PubMed Text format Related articles Abstract available

MALHOTRA HS , Jain KK, Agarwal A, Singh MK, et al
Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
Mult Scler. 2009;15:193-203.
PubMed Text format Related articles Abstract available

FAGIUS J , Lundgren J, Oberg G
Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.
Mult Scler. 2009;15:229-37.
PubMed Text format Related articles Abstract available

January 2009

FEYS P , D'hooghe M, Nagels G, Helsen W, et al
The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BOGOSIAN A , Moss-Morris R, Yardley L, Dennison L, et al
Experiences of partners of people in the early stages of multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MARRIE R , Horwitz R, Cutter G, Tyry T, et al
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

RICO A , Audoin B, Franques J, Eusebio A, et al
Motor evoked potentials in clinically isolated syndrome suggestive of multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

NIELSEN T , Rostgaard K, Askling J, Steffensen R, et al
Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

BENESOVA Y , Vasku A, Novotna H, Litzman J, et al
Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

MATTSSON N , Axelsson M, Haghighi S, Malmestrom C, et al
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ZIPOLI V , Hakiki B, Portaccio E, Lolli F, et al
The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

KAWAJIRI M , Mogi M, Higaki N, Matsuoka T, et al
Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ALI E , Healy B, Stazzone L, Brown B, et al
Daclizumab in treatment of multiple sclerosis patients.
Mult Scler. 2009.
PubMed Text format Related articles Abstract available

ANTEL J , Carroll W, Thompson A
Reflections on 2008.
Mult Scler. 2009;15:1.
PubMed Text format Related articles

SUTTON I , Lahoria R, Tan I, Clouston P, et al
CNS demyelination and quadrivalent HPV vaccination.
Mult Scler. 2009;15:116-9.
PubMed Text format Related articles Abstract available

December 2008

FILIPPI M , Calabrese M, Gallo P
Response letter regarding the article "Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study," by Calabrese, et al.
Mult Scler. 2008.
PubMed Text format Related articles

KORTEWEG T , Rovaris M, Neacsu V, Filippi M, et al
Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

November 2008

ALIX J
Axons and multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles

BROADLEY S , Vanags D, Williams B, Johnson B, et al
Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

PODER K , Ghatavi K, Fisk J, Campbell T, et al
Social anxiety in a multiple sclerosis clinic population.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

RAVNBORG M , Bendtzen K, Christensen O, Jensen P, et al
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

SAWAYA R , Kanso M
Multiple sclerosis in Lebanon: a review of 45 cases.
Mult Scler. 2008.
PubMed Text format Related articles

PFLEGER C , Koch-Henriksen N, Stenager E, Flachs E, et al
Head injury is not a risk factor for multiple sclerosis: a prospective cohort study.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

VAHTER L , Zopp I, Kreegipuu M, Kool P, et al
Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

SEPULCRE J , Masdeu J, Goni J, Arrondo G, et al
Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

OSOEGAWA M , Kira J, Fukazawa T, Fujihara K, et al
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

ATZORI M , Battistella P, Perini P, Calabrese M, et al
Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

TEDESCHI G , Dinacci D, Comerci M, Lavorgna L, et al
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

DE STEFANO N , Filippi M, Confavreux C, Vermersch P, et al
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

NELSON F , Poonawalla A, Hou P, Wolinsky J, et al
3D MPRAGE improves classification of cortical lesions in multiple sclerosis.
Mult Scler. 2008;14:1214-9.
PubMed Text format Related articles Abstract available

MATSUOKA T , Matsushita T, Osoegawa M, Kawano Y, et al
Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis.
Mult Scler. 2008;14:1181-90.
PubMed Text format Related articles Abstract available

MAYO N
Setting the agenda for multiple sclerosis rehabilitation research.
Mult Scler. 2008;14:1154-1156.
PubMed Text format Related articles

ANTEL J , Carroll W, Thompson A
Differential diagnosis of initial isolated clinical presentations.
Mult Scler. 2008;14:1153.
PubMed Text format Related articles

BROCHET B , Deloire MS, Bonnet M, Salort-Campana E, et al
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
Mult Scler. 2008;14:1242-9.
PubMed Text format Related articles Abstract available

October 2008

NICOLETTI A , Patti F, Lo Fermo S, Messina S, et al
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily: an update.
Mult Scler. 2008.
PubMed Text format Related articles

RAUSCH M , Tofts P, Lervik P, Walmsley A, et al
Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f*
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

PETEREIT H , Rubbert-Roth A
Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

MONTIEL-NAVA C , Pena J, Gonzalez-Pernia S, Mora-La Cruz E, et al
Cognitive functioning in children with multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

CABRERA-GOMEZ J , Ramon-Perez L, Saiz A, Llerena-Fernandez P, et al
Neuromyelitis optica and multiple sclerosis in sisters.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

GAJOFATTO A , Bacchetti P, Grimes B, High A, et al
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

JAMROZ-WISNIEWSKA A , Beltowski J, Stelmasiak Z, Bartosik-Psujek H, et al
Paraoxonase 1 activity in different types of multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

GILMORE C , Geurts J, Evangelou N, Bot J, et al
Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

KOPKE S , Kasper J, Muhlhauser I, Nubling M, et al
Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

LINDSEY J , Hatfield L, Crawford M, Patel S, et al
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

VAN DEN ELSKAMP I , Knol D, Uitdehaag B, Barkhof F, et al
The distribution of new enhancing lesion counts in multiple sclerosis: further explorations.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

CATTANEO D , Jonsdottir J
Sensory impairments in quiet standing in subjects with multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

VANOTTI S , Benedict R, Acion L, Caceres F, et al
Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

VALENTINO P , Labate A, Nistico R, Pirritano D, et al
Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

MARRIE R , Horwitz R, Cutter G, Tyry T, et al
High frequency of adverse health behaviors in multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

GRAY O , McDonnell G, Hawkins S
Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

September 2008

RAMAGOPALAN S , Dyment D, Ebers G
Autoimmune disease in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.
Mult Scler. 2008.
PubMed Text format Related articles

PATTI F
Cognitive impairment in multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

IACOBAEUS E , Ryschkewitsch C, Gravell M, Khademi M, et al
Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

MILLER D , Weinshenker B, Filippi M, Banwell B, et al
Differential diagnosis of suspected multiple sclerosis: a consensus approach.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

KOUTSIS G , Panas M, Giogkaraki E, Karadima G, et al
An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

VAN DER VOORT L , Kok A, Visser A, Oudejans C, et al
Interferon-{beta} bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

NOCITI V , Bentivoglio AR, Frisullo G, Fasano A, et al
Movement disorders in multiple sclerosis: causal or coincidental association?
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

CONFAVREUX C , Ritleng C, Debouverie M, Durand-Dubief F, et al
Defining the natural history of multiple sclerosis: the need for complete data and rigorous definitions. Answer to Dr Tremlett et al.
Mult Scler. 2008;14:1144-1147.
PubMed Text format Related articles

MARRIE R , Horwitz R, Cutter G, Tyry T, et al
Comorbidity, socioeconomic status and multiple sclerosis.
Mult Scler. 2008;14:1091-8.
PubMed Text format Related articles Abstract available

FIGVED N , Benedict R, Klevan G, Myhr K, et al
Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis.
Mult Scler. 2008;14:1084-90.
PubMed Text format Related articles Abstract available

GIRONI M , Martinelli-Boneschi F, Sacerdote P, Solaro C, et al
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Mult Scler. 2008;14:1076-83.
PubMed Text format Related articles Abstract available

KURTZKE J
Some contributions of the Department of Veterans Affairs to the epidemiology of multiple sclerosis.
Mult Scler. 2008;14:1007-12.
PubMed Text format Related articles Abstract available

Abstracts of the World Congress on Treatment and Research in Multiple Sclerosis, September 17-20, 2008, Montreal, Canada.
Mult Scler. 2008;14 Suppl 1:S1-314.
PubMed Text format Related articles

TREMLETT H , Zhao Y, Devonshire V
Defining the natural history of MS: the need for complete data and rigorous definitions.
Mult Scler. 2008;14:1142-3.
PubMed Text format Related articles

WEINSTOCK-GUTTMAN B , Miller C, Yeh E, Stosic M, et al
Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
Mult Scler. 2008;14:1061-7.
PubMed Text format Related articles Abstract available

August 2008

POTAGAS C , Mitsonis C, Watier L, Dellatolas G, et al
Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

MILLS RJ , Young CA, Nicholas RS, Pallant JF, et al
Rasch analysis of the Fatigue Severity Scale in multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

CALABRESE M , Filippi M, Rovaris M, Bernardi V, et al
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

OTAEGUI D , Zuriarrain O, Castillo-Trivino T, Aransay AM, et al
Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

THANGARAJH M , Gomez-Rial J, Hedstrom AK, Hillert J, et al
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

SHI N , Kawano Y, Matsuoka T, Mei FJ, et al
Increase of CD4+TNF{alpha}+IL-2-T cells in cerebrospinal fluid of multiple sclerosis patients.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

GIOVANNONI G , Barbarash O, Casset-Semanaz F, King J, et al
Safety and immunogenicity of a new formulation of interferon {beta}-1a (Rebif(R) New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

TAI AK , O'Reilly EJ, Alroy KA, Simon KC, et al
Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

FOX RJ , Kivisakk P, Fisher E, Tucky B, et al
Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

CENTONZE D , Furlan R, Gasperini C, Salvetti M, et al
Early relapses after the first dose of natalizumab in active multiple sclerosis patients.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

KRAGT JJ , van Amerongen BM, Killestein J, Dijkstra CD, et al
Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

PRAKASH RS , Snook EM, Lewis JM, Motl RW, et al
Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

JOHANSSON S , Ytterberg C, Gottberg K, Widen Holmqvist L, et al
Use of health services in people with multiple sclerosis with and without fatigue.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

NIKLAS A , Sebraoui H, Hess E, Wagner A, et al
Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

COCCO E , Sardu C, Gallo P, Capra R, et al
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

INVERNIZZI P , Bonometti MA, Turri E, Benedetti MD, et al
A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble?
Mult Scler. 2008;14:1003-6.
PubMed Text format Related articles Abstract available

COSTELLO F , Hodge W, Pan YI, Eggenberger E, et al
Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography.
Mult Scler. 2008;14:893-905.
PubMed Text format Related articles Abstract available

NIELSEN JM , Uitdehaag BM, Polman CH
Long-term follow-up of suspected though unconfirmed MS.
Mult Scler. 2008;14:985-7.
PubMed Text format Related articles Abstract available

NILSSON P , Rorsman I, Larsson EM, Norrving B, et al
Cognitive dysfunction 24-31 years after isolated optic neuritis.
Mult Scler. 2008;14:913-8.
PubMed Text format Related articles Abstract available

DUQUE B , Sepulcre J, Bejarano B, Samaranch L, et al
Memory decline evolves independently of disease activity in MS.
Mult Scler. 2008;14:947-53.
PubMed Text format Related articles Abstract available

July 2008

SANNA A , Huang YM, Arru G, Fois ML, et al
Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

MAMUTSE G , Woolmore J, Pye E, Partridge J, et al
Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

VAZIRINEJAD R , Lilley J, Ward C
A health profile of adults with multiple sclerosis living in the community.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

SMOLDERS J , Menheere P, Kessels A, Damoiseaux J, et al
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

BECKERMAN H , van Zee IE, de Groot V, van den Bos GA, et al
Utilization of health care by patients with multiple sclerosis is based on professional and patient-defined health needs.
Mult Scler. 2008.
PubMed Text format Related articles Abstract available

PRONK JC , Scheper GC, van Andel RJ, van Berkel CG, et al
No evidence that polymorphisms of the vanishing white matter disease genes are risk factors in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KRAFT GH , Johnson KL, Yorkston K, Amtmann D, et al
Setting the agenda for multiple sclerosis rehabilitation research.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

TEPAVCEVIC DK , Kostic J, Basuroski ID, Stojsavljevic N, et al
The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

FURBY J , Hayton T, Anderson V, Altmann D, et al
Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

GRYTTEN TORKILDSEN N , Lie SA, Aarseth JH, Nyland H, et al
Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

EHRENSPERGER MM , Grether A, Romer G, Berres M, et al
Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

WYNIA K , Middel B, van Dijk JP, De Keyser JH, et al
The impact of disabilities on quality of life in people with multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

SUNDSTROM P , Nystrom L
Smoking worsens the prognosis in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

HIROTANI M , Maita C, Niino M, Iguchi-Ariga SM, et al
Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

BAMER AM , Johnson KL, Amtmann D, Kraft GH, et al
Prevalence of sleep problems in individuals with multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

DI PAULI F , Reindl M, Ehling R, Schautzer F, et al
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

FREEDMAN MS , Forrestal FG
Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon {beta}-1a: analysis of the PRISMS study.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

SCHWARZ S , Knorr C, Geiger H, Flachenecker P, et al
Complementary and alternative medicine for multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

WILKINS A , Scolding N
Protecting axons in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KEZELE I , Arnold D, Collins D
Atrophy in white matter fiber tracts in multiple sclerosis is not dependent on tract length or local white matter lesions.
Mult Scler. 2008;14:779-85.
PubMed Text format Related articles Abstract available

VAN DEN ELSKAMP I , Lembcke J, Dattola V, Beckmann K, et al
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis.
Mult Scler. 2008;14:764-9.
PubMed Text format Related articles Abstract available

HESTVIK A , Skorstad G, Price D, Vartdal F, et al
Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid.
Mult Scler. 2008;14:749-758.
PubMed Text format Related articles Abstract available

TREBST C , Konig F, Ransohoff R, Bruck W, et al
CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions.
Mult Scler. 2008;14:728-33.
PubMed Text format Related articles Abstract available

ROVARIS M , Judica E, Ceccarelli A, Ghezzi A, et al
Absence of diffuse cervical cord tissue damage in early, non-disabling relapsing-remitting MS: a preliminary study.
Mult Scler. 2008;14:853-6.
PubMed Text format Related articles Abstract available

JAVED A , Balabanov R, Arnason BG, Kelly TJ, et al
Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis.
Mult Scler. 2008;14:809-14.
PubMed Text format Related articles Abstract available

GNEISS C , Brugger M, Millonig A, Fogdell-Hahn A, et al
Comparative study of four different assays for the detection of binding antibodies against interferon-beta.
Mult Scler. 2008;14:830-6.
PubMed Text format Related articles Abstract available

MOREH E , Gartsman I, Karussis D, Rund D, et al
Seronegative neuromyelitis optica: improvement following lymphocytapheresis treatment.
Mult Scler. 2008;14:860-1.
PubMed Text format Related articles

SORENSEN PS , Koch-Henriksen N, Flachs EM, Bendtzen K, et al
Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?
Mult Scler. 2008;14:837-42.
PubMed Text format Related articles Abstract available

June 2008

NIELSEN NM , Frisch M, Rostgaard K, Wohlfahrt J, et al
Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KOCH M , Uyttenboogaart M, van Harten AM, De Keyser J, et al
Factors associated with the risk of secondary progression in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

PAUL L , Rafferty D, Young S, Miller L, et al
The effect of functional electrical stimulation on the physiological cost of gait in people with multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KOUTSIS G , Kokotis P, Sarrigiannis P, Anagnostouli M, et al
Spastic paretic hemifacial contracture in multiple sclerosis: a neglected clinical and EMG entity.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

AUDOIN B , Reuter F, Duong MV, Malikova I, et al
Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

TOLEDO J , Sepulcre J, Salinas-Alaman A, Garcia-Layana A, et al
Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

WARREN SA , Svenson LW, Warren KG
Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

HOUZEN H , Niino M, Hata D, Nakano F, et al
Increasing prevalence and incidence of multiple sclerosis in northern Japan.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

GRAY OM , McDonnell GV, Hawkins SA
Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

BOSTER A , Caon C, Perumal J, Hreha S, et al
Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KOCH M , De Keyser J, Tremlett H
Timing of birth and disease progression in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

MARK VW , Taub E, Bashir K, Uswatte G, et al
Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

SENA A , Pedrosa R, Ferret-Sena V, Cascais MJ, et al
Interferon {beta} therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

LEBRUN C , Debouverie M, Jeannin S, Pittion-Vouyovitch S, et al
Impact of disease-modifying treatments in North African migrants with multiple sclerosis in France.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

SELLNER J , Greeve I, Mattle HP
Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

BENEDICT RH , Duquin JA, Jurgensen S, Rudick RA, et al
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

MATYSIAK M , Makosa B, Walczak A, Selmaj K, et al
Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KOCH G , Rossi S, Prosperetti C, Codeca C, et al
Improvement of hand dexterity following motor cortex rTMS in multiple sclerosis patients with cerebellar impairment.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

MIYAZAKI Y , Iwabuchi K, Kikuchi S, Fukazawa T, et al
Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

GOTTBERG K , Einarsson U, Ytterberg C, Fredrikson S, et al
Use of health care services and satisfaction with care in people with multiple sclerosis in Stockholm County: A population-based study.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

SUNDSTROM P , Nystrom L, Jidell E, Hallmans G, et al
EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

PETKAU J , Reingold SC, Held U, Cutter GR, et al
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

WILES CM
Physiotherapy and related activities in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KOCH M , Uyttenboogaart M, van Harten A, Heerings M, et al
Fatigue, depression and progression in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

HELLWIG K , Gold R
Letter to the Editor: Breastfeeding and multiple sclerosis in a German cohort.
Mult Scler. 2008;14:718.
PubMed Text format Related articles

BRAMOW S , Faber-Rod J, Jacobsen C, Kutzelnigg A, et al
Fatal neurogenic pulmonary edema in a patient with progressive multiple sclerosis.
Mult Scler. 2008;14:711-715.
PubMed Text format Related articles Abstract available

BERGER J
Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy.
Mult Scler. 2008;14:708-710.
PubMed Text format Related articles Abstract available

PRUNTY M , Sharpe L, Butow P, Fulcher G, et al
The motherhood choice: Themes arising in the decision-making process for women with multiple sclerosis.
Mult Scler. 2008;14:701-4.
PubMed Text format Related articles Abstract available

NICOLETTI A , Patti F, Lo Fermo S, Sciacca A, et al
Frequency of celiac disease is not increased among multiple sclerosis patients.
Mult Scler. 2008;14:698-700.
PubMed Text format Related articles Abstract available

BLANCO Y , Compta Y, Graus F, Saiz A, et al
Midbrain lesions and paroxysmal dysarthria in multiple sclerosis.
Mult Scler. 2008;14:694-7.
PubMed Text format Related articles Abstract available

GATTI R , Corti M, Govetto S, Bonzani K, et al
Electromyographic activity to keep a lower limb in a raised position in healthy subjects and subjects with multiple sclerosis.
Mult Scler. 2008;14:691-3.
PubMed Text format Related articles Abstract available

MELCON M , Gold L, Carra A, Caceres F, et al
Argentine Patagonia: prevalence and clinical features of multiple sclerosis.
Mult Scler. 2008;14:656-662.
PubMed Text format Related articles Abstract available

MINDEN S , Hoaglin D, Jureidini S, Hadden L, et al
Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study.
Mult Scler. 2008;14:640-655.
PubMed Text format Related articles Abstract available

BOSCA I , Coret F, Valero C, Pascual A, et al
Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon.
Mult Scler. 2008;14:636-9.
PubMed Text format Related articles Abstract available

TUR C , Tintore M, Rovira A, Nos C, et al
Very early scans for demonstrating dissemination in time in multiple sclerosis.
Mult Scler. 2008;14:631-5.
PubMed Text format Related articles Abstract available

ALVAREZ-LAFUENTE R , Garcia-Montojo M, De Las Heras V, Dominguez-Mozo M, et al
Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients.
Mult Scler. 2008;14:595-601.
PubMed Text format Related articles Abstract available

HEBB A , Moore C, Bhan V, Campbell T, et al
Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination.
Mult Scler. 2008;14:577-94.
PubMed Text format Related articles Abstract available

KOBELT G , Berg J, Lindgren P, Jonsson B, et al
Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden.
Mult Scler. 2008;14:679-90.
PubMed Text format Related articles Abstract available

May 2008

IARLORI C , Gambi D, Lugaresi A, Patruno A, et al
Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone(R)).
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KNUDSEN S , Jennum PJ, Korsholm K, Sheikh SP, et al
Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

DRULOVIC J , Riise T, Nortvedt M, Pekmezovic T, et al
Self-rated physical health predicts change in disability in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

HEESEN C , Bohm J, Reich C, Kasper J, et al
Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

STERNBERG Z , Weinstock-Guttman B, Hojnacki D, Zamboni P, et al
Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

FOGLI A , Barbier C, Cournu-Rebeix I, Babron M, et al
Letter to the Editor: No evidence for association between the EIF2B5 gene and multiple sclerosis in French families.
Mult Scler. 2008;14:573.
PubMed Text format Related articles

DALTON CM , Keenan E, Jarrett L, Buckley L, et al
The safety of baclofen in pregnancy: intrathecal therapy in multiple sclerosis.
Mult Scler. 2008;14:571-2.
PubMed Text format Related articles Abstract available

CONTINI C , Seraceni S, Cultrera R, Castellazzi M, et al
Molecular detection of Parachlamydia-like organisms in cerebrospinal fluid of patients with multiple sclerosis.
Mult Scler. 2008;14:564-6.
PubMed Text format Related articles Abstract available

KAWAJIRI M , Mogi M, Osoegawa M, Matsuoka T, et al
Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis.
Mult Scler. 2008;14:557-60.
PubMed Text format Related articles Abstract available

JUNG P , Beyerle A, Ziemann U
Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis.
Mult Scler. 2008;14:553-6.
PubMed Text format Related articles Abstract available

DUNCAN I , Goldman S, Macklin W, Rao M, et al
Stem cell therapy in multiple sclerosis: promise and controversy.
Mult Scler. 2008;14:541-6.
PubMed Text format Related articles Abstract available

LI X , Hemminki K, Sundquist K
Regional, socioeconomic and occupational groups and risk of hospital admission for multiple sclerosis: a cohort study in Sweden.
Mult Scler. 2008;14:522-9.
PubMed Text format Related articles Abstract available

MARTINELLI BONESCHI F , Colombo B, Annovazzi P, Martinelli V, et al
Lifetime and actual prevalence of pain and headache in multiple sclerosis.
Mult Scler. 2008;14:514-21.
PubMed Text format Related articles Abstract available

GRASSO M , Clemenzi A, Tonini A, Pace L, et al
Pain in multiple sclerosis: a clinical and instrumental approach.
Mult Scler. 2008;14:506-13.
PubMed Text format Related articles Abstract available

RIO J , Rovira A, Tintore M, Huerga E, et al
Relationship between MRI lesion activity and response to IFN-{beta} in relapsing-remitting multiple sclerosis patients.
Mult Scler. 2008;14:479-484.
PubMed Text format Related articles Abstract available

TZORTZIS V , Skriapas K, Hadjigeorgiou G, Mitsogiannis I, et al
Sexual dysfunction in newly diagnosed multiple sclerosis women.
Mult Scler. 2008;14:561-3.
PubMed Text format Related articles Abstract available

CARDINAL KS , Wilson SM, Giesser BS, Drain AE, et al
A longitudinal fMRI study of the paced auditory serial addition task.
Mult Scler. 2008;14:465-71.
PubMed Text format Related articles Abstract available

MARIGNIER R , De Seze J, Vukusic S, Durand-Dubief F, et al
NMO-IgG and Devic's neuromyelitis optica: a French experience.
Mult Scler. 2008;14:440-5.
PubMed Text format Related articles Abstract available

SIMO M , Barsi P, Aranyi Z
Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria.
Mult Scler. 2008;14:472-8.
PubMed Text format Related articles Abstract available

April 2008

PUEYO V , Martin J, Fernandez J, Almarcegui C, et al
Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

O'SULLIVAN RJ , Brown IG, Pender MP
Apneusis responding to buspirone in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KRAKAUER M , Sorensen P, Khademi M, Olsson T, et al
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-{beta} treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

VOLLMER T , Panitch H, Bar-Or A, Dunn J, et al
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

BAR-ZOHAR D , Agosta F, Goldstaub D, Filippi M, et al
Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

CHENG Q , Miao L, Zhang J, Guan YT, et al
Clinical features of patients with multiple sclerosis from a survey in Shanghai, China.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

ABO-KRYSHA N , Rashed L
The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

SELLEBJERG F , Datta P, Larsen J, Rieneck K, et al
Gene expression analysis of interferon-{beta} treatment in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

LEBRUN C , Debouverie M, Vermersch P, Clavelou P, et al
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Mult Scler. 2008;14:399-405.
PubMed Text format Related articles Abstract available

CONFAVREUX C
Defining the natural history of MS: the need for complete data and rigorous definitions.
Mult Scler. 2008;14:289-91.
PubMed Text format Related articles

FUVESI J , Bencsik K, Benedek K, Matyas K, et al
Cross-cultural adaptation and validation of the 'Multiple Sclerosis Quality of Life Instrument' in Hungarian.
Mult Scler. 2008;14:391-8.
PubMed Text format Related articles Abstract available

GRABNER R , Popotnig F, Ropele S, Neuper C, et al
Brain activation patterns elicited by the 'Faces Symbol Test' -- a pilot fMRI study.
Mult Scler. 2008;14:354-63.
PubMed Text format Related articles Abstract available

KOCH M , Uyttenboogaart M, Heerings M, Heersema D, et al
Progression in familial and nonfamilial MS.
Mult Scler. 2008;14:300-6.
PubMed Text format Related articles Abstract available

COHEN JA , Calabresi PA, Chakraborty S, Edwards KR, et al
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.
Mult Scler. 2008;14:370-82.
PubMed Text format Related articles Abstract available

March 2008

FLACHENECKER P , Meissner H
Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
Mult Scler. 2008;14:274-7.
PubMed Text format Related articles Abstract available

SERARSLAN G , Okuyucu E, Melek I, Hakverdi S, et al
Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis.
Mult Scler. 2008;14:259-61.
PubMed Text format Related articles Abstract available

CABRERA-GOMEZ J , Saiz-Hinarejos A, Graus F, Gonzalez-Quevedo A, et al
Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders.
Mult Scler. 2008;14:248-51.
PubMed Text format Related articles Abstract available

FARRELL R , Kapoor R, Leary S, Rudge P, et al
Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-beta.
Mult Scler. 2008;14:212-8.
PubMed Text format Related articles Abstract available

SADIQ SA , Rammal M, Sara G
Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MS.
Mult Scler. 2008;14:272-3.
PubMed Text format Related articles Abstract available

WILCOX RA , Burrow J, Slee M, Craig J, et al
Neuromyelitis optica (Devic's disease) in a patient with syphilis.
Mult Scler. 2008;14:268-71.
PubMed Text format Related articles Abstract available

January 2008

MATSUSHITA T , Matsuoka T, Ishizu T, Kikuchi H, et al
Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

TREMLETT H , Zhao Y, Devonshire V
Natural history of secondary-progressive multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

SEVE P , Le Scanff J, Renoux C, Broussolle C, et al
Uveitis associated with multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

GALIMBERTI D , Fenoglio C, Scalabrini D, De Riz M, et al
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KURBAN S , Akpinar Z, Mehmetoglu I
Receptor Activator of Nuclear Factor KappaB Ligand (RANKL) and Osteoprotegerin Levels in Multiple Sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles

CONSTANTINESCU CS , Vilisar J, Harikrishnan S, Suri M, et al
Ehlers-Danlos syndrome and multiple sclerosis: a possible association.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

ZWEMMER JN , Bot JC, Jelles B, Barkhof F, et al
At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

LEONE MA , Bonissoni S, Collimedaglia L, Tesser F, et al
Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

WU XM , Wang C, Zhang KN, Huang G, et al
Balo's disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

TZORTIS V , Skriapas K, Mitsogiannis I, Gravas S, et al
Sexual dysfunction in newly diagnosed multiple sclerosis women.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

PARRATT J , Tavondale R, O'Riordan J, Parratt D, et al
Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

SAUTER C , Zebenholzer K, Zeitlhofer J, Vass K, et al
A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

GRANIERI E , Monaldini C, De Gennaro R, Guttmann S, et al
Multiple sclerosis in the Republic of San Marino: a prevalence and incidence study.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

CORREALE J , Roca M, Fiol M, Martin ME, et al
Cognitive deficits in multiple sclerosis correlate with changes in fronto-subcortical tracts.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KARENBERG A
Multiple sclerosis on-screen: from disaster to coping.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

KALMAN B , Vyshkina T
Linkage disequilibrium analyses within chromosome 19p in multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

RODRIGUES F , Carvalho A, Santos M, Maciel P, et al
T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

MILLER A , Spada V, Beerkircher D, Kreitman RR, et al
Long-term (up to 22 years), open-label,compassionate-use study of glatiramer acetatein relapsingremitting multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

CASADIO M , Sanguineti V, Morasso P, Solaro C, et al
Abnormal sensorimotor control, but intact forcefield adaptation, in multiple sclerosis subjects with no clinical disability.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

HABEK M , Brinar VV, Hajnsek S
The association of multiple sclerosis and Hodgkin's disease: the role of Epstein-Barr virus infection.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

ZAADSTRA BM , Chorus AM, Van Buuren S, Kalsbeek H, et al
Selective association of multiple sclerosis withinfectious mononucleosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

GOERTSCHES R , Baranzini SE, Morcillo C, Nos C, et al
Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

ROVARIS M , Judica E, Sastre-Garriga J, Rovira A, et al
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

FAINARDI E , Rizzo R, Melchiorri L, Stignani M, et al
CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing remitting multiple sclerosis.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

MEHTA LR , Samuelsson MK, Kleiner AK, Goodman AD, et al
Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome.
Mult Scler. 2008;.
PubMed Text format Related articles Abstract available

MCHUGH JC , Galvin PL, Murphy RP
Retrospective comparison of the original and revised McDonald criteria in a general neurology practice in Ireland.
Mult Scler. 2008;14:81-5.
PubMed Text format Related articles Abstract available

November 2007

KOONTZ D , Alshekhlee A
Embolia cutis medicamentosa following interferon beta injection.
Mult Scler. 2007;13:1203-4.
PubMed Text format Related articles

PACHNER AR
Neutralizing anti-IFNbeta antibodies: clarity and confusion.
Mult Scler. 2007;13:1081-2.
PubMed Text format Related articles

TOMASSINI V , De Giglio L, Reindl M, Russo P, et al
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
Mult Scler. 2007;13:1086-94.
PubMed Text format Related articles Abstract available

October 2007

Abstracts of the 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis and the 12th Annual Conference of Rehabilitation in Multiple Sclerosis. October 11-14, 2007. Prague, Czech Republic.
Mult Scler. 2007;13 Suppl 2:S7-273.
PubMed Text format Related articles

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.
Design: